GlaxoSmithKline (GSK) is engaging in wrongful conduct by failing to adequately disclose the risks of Zofran when used by women who are pregnant, according to a new birth defect lawsuit filed by a mother from Tennessee. The lawsuit is pending in the U.S. District Court for the Eastern District of... Read more »

A settlement has been reached between the Kentucky Attorney General and Johnson & Johnson regarding the schizophrenia drug Risperdal. The lawsuit was originally filed with allegations that the pharmaceutical giant and its subsidiary Janssen Pharmaceuticals hid some of the drug’s side effects from consumers, while marketing it for off-label use... Read more »

A recent complaint was filed in the United States District Court for the District of Massachusetts, where it joins the Zofran (Ondansetron) Products Liability Litigation known as MDL 2657. The case centers upon allegations that drug maker GlaxoSmithKline (GSK) negligently marketed its powerful anti-nausea drug to pregnant women without providing... Read more »

According to recently-released research findings, next-generation blood-thinning drug Xarelto may pose additional risk to patients who are already suffering from kidney disease. The study, based on data taken from the Department of Defense electronic medical records system, found that those with existing kidney ailments were significantly more likely to experience... Read more »

In December 2015, non-profit group Public Citizen published a report highlighting a provision in the proposed 21st Century Cures Act that could cost taxpayers $12 billion — and that’s just one of the expenses. The report — written by Sammy Almashat and Sarah Sorscher of Public Citizen’s Health Research Group... Read more »

A new study released by Professor Anick Berard from the University of Montreal has revealed that pregnant women who take antidepressants during the second and/or third trimester ultimately increase the likelihood that their children will receive an autism diagnosis by the time they reach the age of 7. According to the... Read more »

The presiding judge in the coordinated Xarelto lawsuit proceedings has issued a case management order stipulating the injury categories into which cases must be grouped to be considered for potential bellwether trials, which are expected to take place in 2017 as part of the multidistrict litigation (MDL 2592) created to manage... Read more »

  U.S. District Judge Matthew Kennelly of the Northern District of Illinois has issued a schedule of bellwether trials for six Androgel lawsuits. The trials are expected to begin in April and conclude in November of 2017. The issuance of this schedule rejected a request by the defendants to bifurcate... Read more »

A man has been awarded $1.75 million by a jury that determined his breast growth was caused by his use of Risperdal as a child. This is the fourth trial involving the link between Risperdal and male breast growth. The first two also resulted in decisions favoring the plaintiffs and the... Read more »

Thousands of Xarelto users have brought federal lawsuits against the drug’s manufacturers alleging that the anticoagulant caused uncontrollable bleeding and severe injuries. Recent reports shed light on a how the drug made it to the market with FDA approval. The anticoagulant’s drug trial was based on what may have been a... Read more »